Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-11

Clinical Trial Update: PH Sensitive MRI Based Resections of Glioblastoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating pH-sensitive MRI-guided resections for glioblastoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of California, Los Angeles | Conditions: Glioblastoma | Phase 1 | Status: RECRUITING